**Core Concept**
The question targets the enzyme associated with hyperuricemia, which is a condition characterized by elevated serum uric acid levels. This condition can lead to gout, a form of inflammatory arthritis. The underlying principle involves the metabolism of purines, which are broken down into uric acid.

**Why the Correct Answer is Right**
The correct answer is associated with the enzyme xanthine oxidase, which catalyzes the oxidation of hypoxanthine to xanthine and then xanthine to uric acid. This enzyme is responsible for the production of uric acid in the body. Inhibition of xanthine oxidase leads to a reduction in uric acid production, which is the mechanism behind the treatment of hyperuricemia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not directly associated with the production of uric acid.
* **Option B:** This option is incorrect because it is not the primary enzyme responsible for the breakdown of purines to uric acid.
* **Option D:** This option is incorrect because it is not directly involved in the production of uric acid from purines.

**Clinical Pearl / High-Yield Fact**
Allopurinol, a medication used to treat hyperuricemia, is a xanthine oxidase inhibitor. It works by reducing the production of uric acid in the body, thereby preventing the formation of uric acid crystals that cause gout.

**Correct Answer: C. Xanthine oxidase**